Iityhubhu zeLebhu

Imveliso

I-Brimonidine Tartrate 70359-46-5 i-IOP yokunciphisa

Inkcazelo emfutshane:

Izithethantonye:I-Brimonidine-L-Tartrate;Brimonidinne tartrate

Inombolo yeCAS:70359-46-5

Umgangatho:Endlini

Ifomula yemolekyuli:I-C15H16BrN5O6

Ubunzima beFomula:9442.22


Iinkcukacha zeMveliso

Iithegi zeMveliso

Intlawulo:T/T, L/C
Imvelaphi yeMveliso:eTshayina
Indawo yokuthumela ngenqanawa:Beijing/Shanghai/Hangzhou
Umthamo wemveliso:5kg/ngenyanga
Umyalelo(MOQ):1g
Ixesha lokukhokhela:Iintsuku zokusebenza ezi-3
Imeko yokugcina:Igcinwe kwindawo epholileyo, eyomileyo, ubushushu begumbi.
Ipakethe imathiriyeli:ibhotile, ibhotile
Ubungakanani bepakethi:1g/ibhodlela, 5/ibhotile, 10g/ibhotile, 50g/ibhotile, 500g/ibhotile
Ulwazi ngokhuseleko:UN 2811 6.1/PG 3

I-Brimonidine Tartrate

Intshayelelo

IBrimonidine liyeza elisetyenziselwa ukunyanga iglaucoma evulekileyo, uxinzelelo lwamehlo, kunye nerosacea.Kwi-rosacea iphucula ububomvu.Isetyenziswa njengamathontsi esweni okanye igalelwe ulusu.

Iziphumo ebezingalindelekanga eziqhelekileyo xa zisetyenziswa emehlweni ziquka ukurhawuzelelwa, ububomvu, nomlomo owomileyo.Imiphumo eqhelekileyo xa isetyenziswe eluswini ibandakanya ubomvu, ukutshisa, kunye neentloko.Iziphumo ebezingalindelekanga ezibaluleke ngakumbi zinokubandakanya ukuchasana nomzimba kunye noxinzelelo lwegazi oluphantsi.Ukusetyenziswa ekukhulelweni kubonakala kukhuselekile.Xa isetyenziswe kwiso iyasebenza ngokunciphisa inani le-aqueous humor eyenziwe ngelixa inyusa inani elikhupha kwiso.Xa igalelwe eluswini isebenza ngokubangela ukuba imithambo yegazi ihlangane.

Inkcazo (kwimigangatho yendlu)

Into

Inkcazo

Imbonakalo

Umhlophe okanye utyheli kancinci okanye umgubo omdaka kancinci

Ukuchongwa

I-HPLC: Ixesha lokugcinwa kwesampulu ye-HPLC kufuneka ihambelane naleyo yomgangatho wereferensi.
Ilahleko ekomisweni ≤1.0%
Intsalela ekutshisweni ≤0.2%
Iintsimbi ezinzima ≤20ppm
Ukujikeleza okuthe ngqo +9.0°~+10.5°
Izinto eziyeleleneyo (HPLC) Ukungcola okungachazwanga ≤0.1%
Ubumdaka bubonke ≤0.2%
Isivavanyi 99.0%~101.0%

  • Ngaphambili:
  • Okulandelayo: